Finance

Lists
KPL:NSE
Kwality Pharmaceuticals Ltd
₹4,256.50
+1.15%
(+48.60) 1D
Nov 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KPL...
Open
₹4,230.00
High
₹4,299.00
Low
₹4,150.00
Mkt. cap
44.17B
Avg. vol.
48.60K
Volume
42.64K
P/E ratio
46.04
52-wk high
₹4,299.00
52-wk low
₹1,561.00
EPS
₹92.44
No. of employees
1K
Open
₹4,230.00
High
₹4,299.00
Low
₹4,150.00
Mkt. cap
44.17B
Avg. vol.
48.60K
Volume
42.64K
P/E ratio
46.04
52-wk high
₹4,299.00
52-wk low
₹1,561.00
EPS
₹92.44
No. of employees
1K
News stories
From web sources and news partners
About Kwality Pharmaceuticals Ltd
CEO-
Employees1.14K
Founded1983
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 13, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
1.82B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.23B
1.57B
1.62B
1.82B
Cost of goods sold
590.97M
942.31M
874.25M
867.31M
Cost of revenue
590.97M
942.31M
874.25M
867.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.58M
174.62M
147.44M
188.09M
Operating expense
386.86M
291.65M
382.79M
500.50M
Total operating expenses
977.83M
1.23B
1.26B
1.37B
Operating income
256.56M
337.17M
366.48M
452.13M
Other non operating income
-1.00K
2.00K
-1.00K
-1.00K
EBT including unusual items
223.45M
316.68M
339.87M
422.18M
EBT excluding unusual items
231.75M
309.56M
339.87M
422.18M
Income tax expense
63.45M
63.58M
83.65M
131.92M
Effective tax rate
28.40%
20.08%
24.61%
31.25%
Other operating expenses
195.06M
64.39M
185.41M
258.81M
Net income
160.09M
253.01M
256.24M
290.25M
Net profit margin
12.97%
16.10%
15.78%
15.95%
Earnings per share
-
-
-
-
Interest and investment income
-
1.25M
-
-
Interest expense
-24.82M
-28.87M
-26.61M
-29.95M
Net interest expenses
-24.82M
-27.61M
-26.61M
-29.95M
Depreciation and amortization charges
48.22M
52.64M
49.95M
53.60M
EBITDA
302.29M
386.70M
416.00M
503.90M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps